Predictive Biological Factors for Late Survival in Patients with HER2-Positive Breast Cancer

Scientists determined predictive factors for late survival in patients with human epidermal growth factor receptor-2 (HER2)-positive breast cancer. They analyzed 20,672 patients with HER2-positive stage I–III breast cancer.